We are delighted to announce that Oximio Hungary has been granted Good Manufacturing Practice (GMP) and Manufacturing and Importation Authorisation (MIA) certification. The accreditations provide assurance to our customers that we meet the rigorous regulatory...
Oximio is a global end-to-end logistics provider for clinical trials with over 19 years of experience in the industry. Despite the brutal impacts on our Ukrainian founding country in the past year, this has inspired us to strive to deliver not only for the company but...
We are delighted to announce that Oximio Ukraine is represented at the Clinical Trials Subcommittee (CTS) Executive Board at the European Business Association (EBA). Established in 1999, the EBA provides a forum in which members can discuss and find solutions to...
Global Clinical Supplies Group (GCSG) US Conference 23 – 26 April 2023, Orlando (USA) Global Clinical Supplies Group (GSCG) will take place in Orlando (USA), bringing together clinical supply professionals. Each year, over 350 clinical supply professionals...
Oximio Community expresses its deepest condolences and supports the communities affected by the earthquake in Türkiye. We can confirm that our Oximio facility in Türkiye has not been affected, however we feel the pain and understand the devastation caused by this...
We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023. “Compassionate use” allows for a patient outside of clinical trials with a serious or life-threatening disease to...
